S. James Freedman
Plus aucun poste en cours
Profil
S.
James Freedman served as Co-President & Chief Executive Officer at Locus Pharmaceuticals, Inc. in 2009-2010.
He was also a Director at Quikbyte Software, Inc. and Sorrento Therapeutics, Inc. in 2009.
Additionally, he held the position of Executive Vice President-Research & Development at OPKO Health, Inc. Dr. Freedman received his undergraduate degree from McGill University and his doctorate from Tufts University.
Anciens postes connus de S. James Freedman
| Sociétés | Poste | Fin |
|---|---|---|
Sorrento Therapeutics, Inc. /Old/
 Sorrento Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Sorrento Therapeutics, Inc. develops human monoclonal antibodies based on its proprietary technology for research, diagnostic and therapeutic use. The company is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 15/12/2009 |
| SORRENTO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/12/2009 |
| OPKO HEALTH, INC. | Directeur Technique/Scientifique/R&D | - |
Quikbyte Software, Inc.
 Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Directeur/Membre du Conseil | - |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | President | - |
Formation de S. James Freedman
| Tufts University | Doctorate Degree |
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OPKO HEALTH, INC. | Health Services |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
Quikbyte Software, Inc.
Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Finance |
Sorrento Therapeutics, Inc. /Old/
Sorrento Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Sorrento Therapeutics, Inc. develops human monoclonal antibodies based on its proprietary technology for research, diagnostic and therapeutic use. The company is headquartered in San Diego, CA. | Health Technology |
